Induces the gene expression of beta-defensin 2 and human cathelicidin LL-37 that are able to suppress the growth of M. tuberculosis and modulate antimicrobial responses. Adjunct therapy with vitamin D3 enhanced intracellular mycobacterial killing in macrophages, increased sputum culture conversion, and reduced clinical symptoms in TB patients. Here, CAMP is linked to tuberculosis.